Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells.

Abstract:

:Protective protein/cathepsin A (PPCA), a lysosomal carboxypeptidase, is deficient in the neurodegenerative lysosomal disorder galactosialidosis (GS). PPCA(-/-) mice display a disease course similar to that of severe human GS, resulting in nephropathy, ataxia, and premature death. Bone marrow transplantation (BMT) in mutant animals using transgenic BM overexpressing the corrective enzyme in either erythroid cells or monocytes/macrophages has proven effective for the improvement of the phenotype, and encouraged the use of genetically modified BM cells for ex vivo gene therapy of GS. Here, we established stable donor hematopoiesis in PPCA(-/-) mice that received hematopoietic progenitors transduced with a murine stem cell virus (MSCV)-based, bicistronic retroviral vector overexpressing PPCA and the green fluorescent protein (GFP) marker. We observed complete correction of the disease phenotype in the systemic organs up to 10 months after transplantation. PPCA(+) BM-derived cells were detected in all tissues, with the highest expression in liver, spleen, BM, thymus, and lung. In addition, a lysosomal immunostaining was seen in nonhematopoietic cells, indicating efficient uptake of the corrective protein by these cells and cross-correction. Expression in the brain occurred throughout the parenchyma but was mainly localized on perivascular areas. However, PPCA expression in the central nervous system was apparently sufficient to delay the onset of Purkinje cell degeneration and to correct the ataxia. The long-term expression and internalization of the PPCA by cells of systemic organs and the clear improvement of the neurologic phenotype support the use of this approach for the treatment of GS in humans. (Blood. 2002;99:3169-3178)

journal_name

Blood

journal_title

Blood

authors

Leimig T,Mann L,Martin Mdel P,Bonten E,Persons D,Knowles J,Allay JA,Cunningham J,Nienhuis AW,Smeyne R,d'Azzo A

doi

10.1182/blood.v99.9.3169

subject

Has Abstract

pub_date

2002-05-01 00:00:00

pages

3169-78

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

99

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

    abstract::Hairy cell leukemia (HCL) is marked by near 100% mutational frequency of BRAFV600E mutations. Recurrent cooperating genetic events that may contribute to HCL pathogenesis or affect the clinical course of HCL are currently not described. Therefore, we performed whole exome sequencing to explore the mutational landscape...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-643361

    authors: Dietrich S,Hüllein J,Lee SC,Hutter B,Gonzalez D,Jayne S,Dyer MJ,Oleś M,Else M,Liu X,Słabicki M,Wu B,Troussard X,Dürig J,Andrulis M,Dearden C,von Kalle C,Granzow M,Jauch A,Fröhling S,Huber W,Meggendorfer M,Hafe

    更新日期:2015-08-20 00:00:00

  • Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.

    abstract::An association between platelets, angiogenesis, and cancer has long been recognized, but the mechanisms linking them remains unclear. Platelets regulate new blood vessel growth through numerous stimulators and inhibitors of angiogenesis by several pathways, including differential exocytosis of angiogenesis regulators....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-334524

    authors: Battinelli EM,Markens BA,Italiano JE Jr

    更新日期:2011-08-04 00:00:00

  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

    abstract::Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation and rates of subsequent clinical outcomes among patients chronically anticoagulated with warfarin or apixaban. We recorded whether (and for how long) anticoagulant therapy was interrupted preprocedure, whether bridging therapy was ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-08-595496

    authors: Garcia D,Alexander JH,Wallentin L,Wojdyla DM,Thomas L,Hanna M,Al-Khatib SM,Dorian P,Ansell J,Commerford P,Flaker G,Lanas F,Vinereanu D,Xavier D,Hylek EM,Held C,Verheugt FW,Granger CB,Lopes RD

    更新日期:2014-12-11 00:00:00

  • Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.

    abstract::Even if neoplastic cells express tumor associated antigens they still may fail to function as antigen presenting cells (APC) if they lack expression of one or more molecules critical for the induction of productive immunity. These cellular defects can be repaired by physiologic activation, transfection, or fusion of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cardoso AA,Schultze JL,Boussiotis VA,Freeman GJ,Seamon MJ,Laszlo S,Billet A,Sallan SE,Gribben JG,Nadler LM

    更新日期:1996-07-01 00:00:00

  • The mechanism of platelet release.

    abstract::The mechanism of platelet release has been studied in mouse bone marrow, using scanning and transmission electron microscopy. Cytoplasmic processes extended into sinusoids by megakaryocytes were found to undergo attenuation, and at the distal end develop constrictions between segments of platelet size. Rupture at site...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Radley JM,Scurfield G

    更新日期:1980-12-01 00:00:00

  • CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

    abstract::CD10/neutral endopeptidase 24.11 (NEP) regulates peptidemediated proliferation of lymphoid progenitors and certain epithelial cells and is itself regulated by cellular proliferation. To further characterize mechanisms by which cell-surface signaling might regulate CD10/NEP expression, we determined whether CD10/NEP wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganju RK,Shpektor RG,Brenner DG,Shipp MA

    更新日期:1996-12-01 00:00:00

  • Thrombosis in primary myelofibrosis: incidence and risk factors.

    abstract::We assessed frequency and predictive factors for major cardiovascular (CV) events in 707 patients with primary myelofibrosis (PMF) followed in 4 European institutions. A total of 236 deaths (33%) were recorded for an overall mortality of 7.7% patient-years (pt-yr). Fatal and nonfatal thromboses were registered in 51 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-238956

    authors: Barbui T,Carobbio A,Cervantes F,Vannucchi AM,Guglielmelli P,Antonioli E,Alvarez-Larrán A,Rambaldi A,Finazzi G,Barosi G

    更新日期:2010-01-28 00:00:00

  • The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells.

    abstract::The relationship between class switch recombination (CSR) and somatic hypermutation has been unclear. By using human CD27(-) naive B cells, we investigated the somatic hypermutation and producibility of immunoglobulins (Igs) that occur after CSR. Although neither adult CD27(-) nor cord blood B cells, which showed the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.2.567

    authors: Nagumo H,Agematsu K,Kobayashi N,Shinozaki K,Hokibara S,Nagase H,Takamoto M,Yasui K,Sugane K,Komiyama A

    更新日期:2002-01-15 00:00:00

  • Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

    abstract::Zosuquidar, which modulates P-glycoprotein (P-gp) with minimal delay of anthracycline clearance, may reverse P-gp-mediated resistance in acute myeloid leukemia without increased toxicity. A total of 449 adults older than 60 years with acute myeloid leukemia or high-risk myelodysplastic syndrome enrolled in a randomize...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-04-277269

    authors: Cripe LD,Uno H,Paietta EM,Litzow MR,Ketterling RP,Bennett JM,Rowe JM,Lazarus HM,Luger S,Tallman MS

    更新日期:2010-11-18 00:00:00

  • Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer.

    abstract::Stem cell factor (SCF) binding to the c-kit receptor triggers homodimerization and intermolecular tyrosine phosphorylation of the c-kit receptor, thus initiating signal transduction. Receptor dimerization is a critical early step in this process. Prior biochemical studies of c-kit receptor dimerization have mainly use...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broudy VC,Lin NL,Bühring HJ,Komatsu N,Kavanagh TJ

    更新日期:1998-02-01 00:00:00

  • Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes.

    abstract::Macrophage colony-stimulating factor (M-CSF or CSF-1) and granulocyte-macrophage CSF (GM-CSF) have been shown to increase human monocyte urokinase-type plasminogen-activator (u-PA) activity with possible consequences for cell migration and tissue remodeling; because monocyte u-PA activity is likely to be controlled in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamilton JA,Whitty GA,Stanton H,Wojta J,Gallichio M,McGrath K,Ianches G

    更新日期:1993-12-15 00:00:00

  • Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.

    abstract::We prospectively studied 98 chronic myeloid leukemia (CML) patients after bone marrow transplantation by competitive polymerase chain reaction to detect and quantify leukemia-specific BCR-ABL mRNA. Of 69 patients who had persistently undetectable, decreasing, or low BCR-ABL levels ( < 50 transcripts/microgram RNA) on ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lin F,van Rhee F,Goldman JM,Cross NC

    更新日期:1996-05-15 00:00:00

  • In vitro regulation of granulopoiesis in human leukemia: application of an assay for colony-inhibiting cells.

    abstract::We describe two assays to detect the action of colony-inhibiting cells. In the first assay, we used a simple density separation technique to remove dense neutrophils (PMN) from suspensions of blood and of bone marrow cells prior to culture in semisolid agar. Conditions were arranged to ensure that control suspensions ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Baker FL,Galbraith PR

    更新日期:1976-03-01 00:00:00

  • Congenital dyserythropoietic anemias.

    abstract::Congenital dyserythropoietic anemias (CDAs) are a heterogeneous group of inherited anemias that affect the normal differentiation-proliferation pathways of the erythroid lineage. They belong to the wide group of ineffective erythropoiesis conditions that mainly result in monolinear cytopenia. CDAs are classified into ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000948

    authors: Iolascon A,Andolfo I,Russo R

    更新日期:2020-09-10 00:00:00

  • HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.

    abstract::The finding that the risk of relapse in hematologic malignancy decreases after allogeneic hematopoietic stem cell transplantation (HSCT) has lead to the concept of a graft-versus-leukemia (GVL) effect. However, this beneficial effect is considered to be frequently offset by graft-versus-host disease (GVHD). Thus, impr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-171934

    authors: Kawase T,Matsuo K,Kashiwase K,Inoko H,Saji H,Ogawa S,Kato S,Sasazuki T,Kodera Y,Morishima Y,Japan Marrow Donor Program.

    更新日期:2009-03-19 00:00:00

  • Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.

    abstract::The anticoagulant warfarin has >30 million prescriptions per year in the United States. Doses can vary 20-fold between patients, and incorrect dosing can result in serious adverse events. Variation in warfarin pharmacokinetic and pharmacodynamic genes, such as CYP2C9 and VKORC1, do not fully explain the dose variabili...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-568436

    authors: Daneshjou R,Gamazon ER,Burkley B,Cavallari LH,Johnson JA,Klein TE,Limdi N,Hillenmeyer S,Percha B,Karczewski KJ,Langaee T,Patel SR,Bustamante CD,Altman RB,Perera MA

    更新日期:2014-10-02 00:00:00

  • Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.

    abstract::Hepcidin is the master regulator of iron homeostasis. In the liver, iron-dependent hepcidin activation is regulated through Bmp6 and its membrane receptor hemojuvelin (Hjv), whereas, in response to iron deficiency, hepcidin repression seems to be controlled by a pathway involving the serine protease matriptase-2 (enco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-295147

    authors: Lenoir A,Deschemin JC,Kautz L,Ramsay AJ,Roth MP,Lopez-Otin C,Vaulont S,Nicolas G

    更新日期:2011-01-13 00:00:00

  • Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.

    abstract::In the absence of conclusive assays capable of determining the functionality of ex vivo expanded human hematopoietic progenitor cells, we combined cell tracking with the membrane dye PKH2, immunostaining for CD34, and limiting dilution analysis to estimate the frequency of long-term hematopoietic culture-initiating ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Traycoff CM,Kosak ST,Grigsby S,Srour EF

    更新日期:1995-04-15 00:00:00

  • Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.

    abstract::Toll-like receptors (TLRs) are able to interact with pathogen-derived products and their signals induce the coordinated activation of innate and adaptive immune mechanisms. Dendritic cells (DCs) play a central role in these events. As the different TLRs are able to trigger MyD88/TRIF-dependent and -independent signali...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4015

    authors: Warger T,Osterloh P,Rechtsteiner G,Fassbender M,Heib V,Schmid B,Schmitt E,Schild H,Radsak MP

    更新日期:2006-07-15 00:00:00

  • Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.

    abstract::The importance of glutamine (Gln) metabolism in multiple myeloma (MM) cells and its potential role as a therapeutic target are still unknown, although it has been reported that human myeloma cell lines (HMCLs) are highly sensitive to Gln depletion. In this study, we found that both HMCLs and primary bone marrow (BM) C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-690743

    authors: Bolzoni M,Chiu M,Accardi F,Vescovini R,Airoldi I,Storti P,Todoerti K,Agnelli L,Missale G,Andreoli R,Bianchi MG,Allegri M,Barilli A,Nicolini F,Cavalli A,Costa F,Marchica V,Toscani D,Mancini C,Martella E,Dall'Asta V

    更新日期:2016-08-04 00:00:00

  • The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells.

    abstract::The majority of mouse Vα14 invariant natural killer T (Vα14i NKT) cells produce several cytokines, including IFNγ and IL-4, very rapidly after activation. A subset of these cells, known as NKT17 cells, however, differentiates in the thymus to preferentially produce IL-17. Here, we show that the transcription factor-kn...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-406280

    authors: Engel I,Zhao M,Kappes D,Taniuchi I,Kronenberg M

    更新日期:2012-11-29 00:00:00

  • Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.

    abstract::Rapid exclusion of heparin-induced thrombocytopenia (HIT) is needed to determine which patients can continue to receive heparin. In this prospective management study, 526 participants had a 4Ts score, rapid particle gel immunoassay (platelet factor 4/heparin [PF4/H]-PaGIA), and serotonin-release assay (SRA) performed....

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2014-12-618165

    authors: Linkins LA,Bates SM,Lee AY,Heddle NM,Wang G,Warkentin TE

    更新日期:2015-07-30 00:00:00

  • Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.

    abstract::Liver injury is a frequent, serious complication of allogeneic hematopoietic cell transplantation (HCT) following myeloablative preparative regimens. We sought to determine the frequency and severity of hepatic injury after nonmyeloablative conditioning and its relationship to outcomes. One hundred ninety-three consec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1311

    authors: Hogan WJ,Maris M,Storer B,Sandmaier BM,Maloney DG,Schoch HG,Woolfrey AE,Shulman HM,Storb R,McDonald GB

    更新日期:2004-01-01 00:00:00

  • Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study.

    abstract::Genetic risk factors contribute to adverse outcome of hematopoietic stem cell transplantation (HSCT). Mismatching of the HLA complex most strongly determines outcomes, whereas non-HLA genetic polymorphisms are also having an impact. Although the majority of HSCTs are mismatched, only few studies have investigated the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-406785

    authors: Harkensee C,Oka A,Onizuka M,Middleton PG,Inoko H,Hirayasu K,Kashiwase K,Yabe T,Nakaoka H,Gennery AR,Ando K,Morishima Y,Japan Marrow Donor Program.

    更新日期:2012-06-28 00:00:00

  • Leukemia-associated antigens in ALL.

    abstract::A cytotoxic common ALL antiserum (CALLA) specific for leukemic cells of most patients with non-T-cel- acute lymphoblastic leukemia (ALL) and of some patients with chronic myelogenous leukemia (CML) in blast crisis has been reproducibly prepared using cell lines for absorption. CALLA reacts with leukemic cells of 110 o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pesando JM,Ritz J,Lazarus H,Costello SB,Sallan S,Schlossman SF

    更新日期:1979-12-01 00:00:00

  • Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.

    abstract::Ectopic expression of fibroblast growth factor receptor 3 (FGFR3) associated with t(4;14) has been implicated in the pathogenesis of human multiple myeloma. Some t(4;14) patients have activating mutations of FGFR3, of which a minority are K650E (thanatophoric dysplasia type II [TDII]). To investigate the role of autop...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-09-3686

    authors: Chen J,Williams IR,Lee BH,Duclos N,Huntly BJ,Donoghue DJ,Gilliland DG

    更新日期:2005-07-01 00:00:00

  • A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIa expressed on stored and activated platelets.

    abstract::We prepared a heterohybrid cell line that secretes a human IgM monoclonal autoantibody that recognizes an antigen found on thrombin-activated or stored platelets. The surface expression of the epitope recognized by this autoantibody, 5E5, increases with time as platelets age in vitro, suggesting that it may represent ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nugent DJ,Kunicki TJ,Berglund C,Bernstein ID

    更新日期:1987-07-01 00:00:00

  • Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus.

    abstract::Kaposi sarcoma-associated herpesvirus (KSHV) is associated with KS, primary effusion lymphoma (PEL), and multicentric Castleman disease. Reactivation of KSHV in latently infected cells and subsequent plasma viremia occur before the development of KS. Intracellular signaling pathways involved in KSHV reactivation were ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.8.2374

    authors: Zoeteweij JP,Moses AV,Rinderknecht AS,Davis DA,Overwijk WW,Yarchoan R,Orenstein JM,Blauvelt A

    更新日期:2001-04-15 00:00:00

  • Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.

    abstract::Immunosuppressive therapy can produce hematologic improvement in a large proportion of patients with severe aplastic anemia. Antithymocyte globulin (ATG) is the current treatment of choice for patients who do not have histocompatible sibling donors or who are otherwise inegligible for allogeneic bone marrow transplant...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Rosenfeld SJ,Kimball J,Vining D,Young NS

    更新日期:1995-06-01 00:00:00

  • TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release.

    abstract::Exposure of endothelial cells to recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced a modest (2-fold) increase of HL-60 cell adhesion as compared to TNF-alpha (40-fold) or interleukin 1beta (IL-1beta; 20-fold). However, pretreatment of endothelial cultures with TRAIL determined a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-4111

    authors: Secchiero P,Corallini F,di Iasio MG,Gonelli A,Barbarotto E,Zauli G

    更新日期:2005-05-01 00:00:00